Mechanisms Regulating Myeloma Cell Responsiveness to Antisense Oligonucleotides Targeting IRF4

被引：1
|
作者：
Shirasaki, Ryosuke
Algarin, Esperanza M.
Simoes, Ricardo De Matos
Downey-Kopyscinski, Sondra L.
Yamano, Shizuka
Luo, Xiaolin
Kim, Youngsoo
MacLeod, Robert
Mitsiades, Constantine S.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142518
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting SWI/SNF Extinguishes IRF4 Expression in Multiple Myeloma
    Bolomsky, Arnold
    Muppidi, Jagan
    Thomas, Craig
    Young, Ryan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S24 - S24
  • [2] IRF4 addiction in multiple myeloma
    Arthur L. Shaffer
    N. C. Tolga Emre
    Laurence Lamy
    Vu N. Ngo
    George Wright
    Wenming Xiao
    John Powell
    Sandeep Dave
    Xin Yu
    Hong Zhao
    Yuxin Zeng
    Bangzheng Chen
    Joshua Epstein
    Louis M. Staudt
    Nature, 2008, 454 : 226 - 231
  • [3] IRF4 addiction in multiple myeloma
    Shaffer, Arthur L.
    Emre, N. C. Tolga
    Lamy, Laurence
    Ngo, Vu N.
    Wright, George
    Xiao, Wenming
    Powell, John
    Dave, Sandeep
    Yu, Xin
    Zhao, Hong
    Zeng, Yuxin
    Chen, Bangzheng
    Epstein, Joshua
    Staudt, Louis M.
    NATURE, 2008, 454 (7201) : 226 - 231
  • [4] Targeting IRF4 in autoimmune diseases
    Xu, Wang-Dong
    Pan, Hai-Feng
    Ye, Dong-Qing
    Xu, Yuekang
    AUTOIMMUNITY REVIEWS, 2012, 11 (12) : 918 - 924
  • [5] IRF4 promotes cell proliferation by JNK pathway in multiple myeloma
    Zhang, Sensen
    Xu, Jiaren
    Wu, Shuang
    Wang, Rong
    Qu, Xiaoyan
    Yu, Wenjun
    Li, Jiangyong
    Chen, Lijuan
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [6] IRF4 promotes cell proliferation by JNK pathway in multiple myeloma
    Sensen Zhang
    Jiaren Xu
    Shuang Wu
    Rong Wang
    Xiaoyan Qu
    Wenjun Yu
    Jiangyong Li
    Lijuan Chen
    Medical Oncology, 2013, 30
  • [7] Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption
    Mondala, Phoebe K.
    Vora, Ashni A.
    Zhou, Tianyuan
    Lazzari, Elisa
    Ladel, Luisa
    Luo, Xiaolin
    Kim, Youngsoo
    Costello, Caitlin
    MacLeod, A. Robert
    Jamieson, Catriona H. M.
    Crews, Leslie A.
    CELL STEM CELL, 2021, 28 (04) : 623 - +
  • [8] Cereblon Binding IMiD Small Molecules Mediate Myeloma Cell Death Via IRF4
    Zhu, Yuan Xiao
    Shi, Chang-Xin
    Bruins, Laura
    Kortuem, Klaus Martin
    Schmidt, Jessica
    Chang, Xiu-Bao
    Braggio, Esteban
    Bergsagel, Leif
    Stewart, Keith
    BLOOD, 2012, 120 (21)
  • [9] IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma
    Bolomsky, Arnold
    Ceribelli, Michele
    Scheich, Sebastian
    Rinaldi, Kristina
    Huang, Da Wei
    Chakraborty, Papiya
    Pham, Lisette
    Wright, George W.
    Hsiao, Tony
    Morris, Vivian
    Choi, Jaewoo
    Phelan, James D.
    Holewinski, Ronald J.
    Andresson, Thorkell
    Wisniewski, Jan
    Riley, Deanna
    Pittaluga, Stefania
    Hill, Elizabeth
    Thomas, Craig J.
    Muppidi, Jagan
    Young, Ryan M.
    CANCER CELL, 2024, 42 (07) : 1185 - 1201.e14
  • [10] Lenalidomide Inhibits the Multiple Myeloma Cell Survival Factor IRF4/MUM1
    Lopez-Girona, A.
    Mendy, D.
    Gaidarova, S.
    Brady, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S122 - S122
12345